MON - Monsanto Company

. Currency in USD
-
-
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters6 hours ago

    Exclusive: U.S. seed sellers push for limits on Monsanto, BASF weed killer

    America's two biggest independent seed sellers, Beck's Hybrids and Stine Seed, told Reuters they are pushing U.S. environmental regulators to bar farmers from spraying dicamba weed killer during upcoming summers in a potential blow to Bayer AG's Monsanto Co. Limiting spraying of the chemical to the spring season, before crops are planted, would prevent farmers from using the herbicide on dicamba-resistant soybeans that Monsanto engineered. The seeds are sold by companies including Beck's and Stine.

  • Bayer says can begin integration of Monsanto
    Reuters11 hours ago

    Bayer says can begin integration of Monsanto

    Bayer can begin folding Monsanto into its organisation as the antitrust-related sale of assets has been completed, fulfilling final requirements by the U.S. Department of Justice, the German drugmaker said on Thursday. "The integration of Monsanto into the Bayer Group can begin following the completion on Thursday of the divestment by Bayer to BASF of certain Crop Science businesses with a total sales volume of around 2.2 billion euros," it said in a statement. Bayer already closed the deal, becoming the sole owner of Monsanto, on June 7 but had to hold off on the integration.

  • Reuters2 days ago

    Analysis: Monsanto Roundup appeal has uphill climb on 'junk science' grounds - legal experts

    Bayer AG unit Monsanto faces long odds on an appeal blaming an "inflamed" jury and "junk science" for a verdict of $289 million in damages to a man who said the company's Roundup weed killer caused his cancer, according to some legal experts. Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide.

  • Roundup cancer verdict sends Bayer shares sliding
    Reuters3 days ago

    Roundup cancer verdict sends Bayer shares sliding

    Bayer (BAYGn.DE) shares plunged as much as 14 percent on Monday, losing about $14 billion (£10.95 billion) in value, after newly acquired Monsanto was ordered to pay $289 million in damages in the first of possibly thousands of U.S. lawsuits over alleged links between a weedkiller and cancer. After the verdict in favour of a California school groundskeeper with terminal cancer, Monsanto faces more than 5,000 similar lawsuits across the United States over claims it did not warn of the cancer risks of glyphosate-based weedkillers, including its Roundup brand. Monsanto, bought by Bayer this year for $63 billion, said that it would appeal against the jury's verdict in California, which is the latest episode in a long-running debate over claims that exposure to Roundup can cause cancer.

  • Monsanto ordered to pay $289m to terminally ill groundsman who used Roundup weedkiller
    The Telegraph6 days ago

    Monsanto ordered to pay $289m to terminally ill groundsman who used Roundup weedkiller

    Monsanto ordered to pay $289m to terminally ill groundsman who used Roundup weedkiller

  • Jury backs man who claims Roundup weed killer caused cancer
    Associated Press6 days ago

    Jury backs man who claims Roundup weed killer caused cancer

    SAN FRANCISCO (AP) — A San Francisco jury on Friday ordered agribusiness giant Monsanto to pay $289 million to a former school groundskeeper dying of cancer, saying the company's popular Roundup weed killer contributed to his disease.

  • Reuters6 days ago

    Monsanto ordered to pay $289 million in world's first Roundup cancer trial

    The case of school groundskeeper Dewayne Johnson was the first lawsuit to go to trial alleging glyphosate causes cancer. Monsanto, a unit of Bayer AG (BAYGn.DE) following a $62.5 billion acquisition by the German conglomerate, faces more than 5,000 similar lawsuits across the United States. The jury at San Francisco's Superior Court of California deliberated for three days before finding that Monsanto had failed to warn Johnson and other consumers of the cancer risks posed by its weed killers.

  • InvestorPlacelast month

    Tesla Inc Whistleblower Continues to Rile Musk

    Martin Tripp, a former employee of Tesla Inc (NASDAQ:TSLA), is not backing down. The allegations include misleading statements from Tesla Inc about production levels of the Model 3 (by as much as 44%), damaged batteries (that included punctures) and the reuse of old parts. Well, Tesla Inc believes that Tripp hacked confidential information and provided it to third parties.

  • Monsanto’s Roundup Is on Trial. The Charge: Causing Cancer
    Fortunelast month

    Monsanto’s Roundup Is on Trial. The Charge: Causing Cancer

    The weed killer has been blamed for a former gardener's non-Hodgkin lymphoma.

  • Associated Presslast month

    Business Highlights

    As the trade war between the world's two largest economies nears the end of its first week, its most unsettling fact may be this: No one seems to foresee any clear path to peace. The United States insists that China abandon the brass-knuckles tactics it's used to try to supplant America's technological dominance. WASHINGTON (AP) -- Business groups and labor unions have lined up on opposing sides of the pitched battle shaping up over President Donald Trump's Supreme Court nominee, Brett Kavanaugh, whose approach to the law is widely seen as business-friendly.

  • Lawsuits alleging Roundup caused cancer can move forward
    Associated Presslast month

    Lawsuits alleging Roundup caused cancer can move forward

    SAN FRANCISCO (AP) — Hundreds of lawsuits alleging Roundup weed killer caused cancer cleared a big hurdle Tuesday when a U.S. judge ruled that cancer victims and their families could present expert testimony linking the herbicide to non-Hodgkin's lymphoma.

  • Reuterslast month

    U.S. judge allows lawsuits over Monsanto's Roundup to proceed to trial

    The decision by U.S. District Judge Vince Chhabria in San Francisco, California, followed years of litigation and weeks of hearings about the controversial science surrounding the safety of the chemical glyphosate, the key ingredient in Monsanto's top-selling weed-killer. Monsanto is a unit of Bayer AG (BAYGn.DE), following the $62.5 billion takeover of the U.S. seed major which wrapped up in June.

  • Monsanto may appeal Brazil royalties ruling
    Reuterslast month

    Monsanto may appeal Brazil royalties ruling

    Monsanto Co is considering appealing a Brazilian court ruling obliging it to deposit in an escrow account the royalties related to its Intacta RR2 Pro soy seed biotechnology, the company said in a statement on Tuesday. "Monsanto is weighing options for appealing (the ruling) and will take all measures to protect its legal rights," the statement said. Last week, a Brazilian judge ordered units of Monsanto Co to deposit the royalties related to that genetically modified seed in an escrow account pending the outcome of litigation over a patent dispute between Brazilian soy growers and the U.S. seeds company, now a unit of Bayer AG.

  • First trial over Roundup weed killer cancer claim under way
    Associated Presslast month

    First trial over Roundup weed killer cancer claim under way

    SAN FRANCISCO (AP) — Lawyers for a school groundskeeper dying of cancer asked a San Francisco jury on Monday to find that agribusiness giant Monsanto's widely used weed killer Roundup likely caused his disease.

  • Reuterslast month

    Brazil judge orders Monsanto to deposit royalties related to GMO seed

    A Brazilian judge has ordered local units of Monsanto Co to put royalties related to a GMO soy seed technology in an escrow account, in a decision likely to hinder the U.S. seed company's ability to collect royalties from the business. The July 3 ruling relates to a patent dispute between Brazilian soy growers in the state of Mato Grosso and Monsanto, which was recently acquired by Germany's Bayer AG in a 63 billion-euro deal. The judge ordered local units of Monsanto to deposit in an escrow account royalties related to the Intacta RR2 Pro genetically modified soy seed technology pending the end of the patent litigation, according to the decision seen by Reuters.

  • Moody's2 months ago

    Monsanto Finance Canada Co. -- Moody's downgrades Monsanto's ratings to Baa1; outlook negative

    Moody's Investors Service, ("Moody's") downgraded Monsanto Company's (Monsanto's) and Monsanto Finance Canada Co.'s long-term debt ratings to Baa1 from A3 due to its acquisition by Bayer AG (Baa1 negative) on June 7, 2018. Moody's also withdrew Monsanto's Prime-2 commercial paper rating.

  • Bayer closes $62.5 billion acquisition of Monsanto
    American City Business Journals2 months ago

    Bayer closes $62.5 billion acquisition of Monsanto

    Bayer has closed its $62.5 billion acquisition of Creve Coeur-based Monsanto Co. Monsanto shares (NYSE: MON) closed at $127.95 each Wednesday, they're last day of trading. The deal was first announced in September 2016 and Germany-based Bayer last week won U.S. approval for the Monsanto takeover after months of delays. There will be no branding changes to the company until Bayer completes several divestitures to BASF, according to a release.

  • ETF Trends2 months ago

    Twitter, Netflix to Join Large-Cap S&P Index ETFs

    Large-cap ETF investors may soon see some big tech names in their portfolios as Twitter (TWTR) will join the S&P 500 before trading Thursday while Netflix (NFLX) will replace Monsanto (MON) in the S&P 100. Monsanto, the agricultural company, is being acquired by German pharmaceutical and chemical conglomerate Bayer AG in a deal expected to be finished soon.

  • Reuters2 months ago

    U.S. farmers, agribusiness feel lingering strain from cold, wet spring

    U.S. agribusinesses are facing lingering inventory snafus and economic pain over farm chemicals and fertilizer, as a cold, wet spring that slowed crop plantings continues to cause ripple effects across the agricultural sector. Farmers fell behind on planting corn in April due to the unfavorable weather, shortening the window for applications of products such as fertilizer and herbicides.

  • TheStreet.com2 months ago

    Out With the Old: S&P 500 Welcomes Twitter

    The metaphor should be lost on no one: it's the first generational change to the S&P 500 and it must be hailed as the beginning of the end of the old-school companies and a new chapter for the new school of businesses and their ethos. When Bayer AG announced the acquisition of Monsanto two years ago, Monsanto was already viewed with skepticism as a company because of its creation of Agent Orange, the American scourge during the Vietnam War, and the pioneering work toward genetically modified seeds, the GMOs that so many millennials despise. How controversial, how reviled is Monsanto?

  • Cramer: Twitter's move into the S&P 500 is a metaphor for where business is headed
    CNBC2 months ago

    Cramer: Twitter's move into the S&P 500 is a metaphor for where business is headed

    Jim Cramer muses on what Twitter's entry into the S&P 500 index means for the future of the stock market.

  • Monsanto is about to disappear. Everything will stay exactly the same
    Quartz2 months ago

    Monsanto is about to disappear. Everything will stay exactly the same

    German pharmaceutical giant Bayer will officially buy US agriculture giant Monsanto on Thursday (June 7) for $63 billion, after securing approval for the deal from US and European regulators. Bayer announced they will immediately retire the 117-year-old Monsanto name. Monsanto is the world’s biggest supplier of genetically modified seeds, and the name “Monsanto” has become…

  • InvestorPlace2 months ago

    Twitter Inc Replaces Monsanto in S&P 500 — Now What?

    Shares of Twitter Inc (NYSE:TWTR) are enjoying a nice boost Tuesday, up more than 5%. The move comes on news that TWTR stock will replace Monsanto Company (NYSE:MON) in the S&P 500. Twitter’s move into the S&P 500 is extending the 52-week highs that TWTR stock set on Monday.

  • Investopedia2 months ago

    Twitter Stock Breaks Out on S&P 500 Inclusion

    Twitter, Inc. ( TWTR) shares rose nearly 5% in early trading on Tuesday morning after it emerged that the company would replace Monsanto Company ( MON) in the S&P 500 Index after Monsanto's transaction with Bayer AG ( BAYRY) is completed on June 7. At the same time, Variety reported that Twitter broke up its live video business and consolidated those responsibilities to its content partnerships team in a reorganization that could streamline its operations. Cascend Securities raised its price target on Twitter from $40 to $45 per share following the news, which represents a nearly 20% premium to Monday's close.

  • Can Trump win on trade with little support at home?
    Yahoo Finance Video2 months ago

    Can Trump win on trade with little support at home?

    Following a tense G7, President Trump struggles to find support for his trade policies at home. Yahoo Finance's Seana Smith, Andy Serwer and Julia La Roche discuss.